Search

everythinglearnresearchcommunity

for

Search:↓

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Adipose-derived stem cells may help with hair loss, but more research is needed.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

Microneedling with platelet-rich plasma and minoxidil improves hair growth more than just minoxidil in men with hair loss.

Androgenetic alopecia is significantly linked to metabolic syndrome.

Phyllanthus niruri extract may help treat hair loss by promoting hair growth and blocking a hair loss-related enzyme.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Metformin might help treat certain skin conditions, but more research is needed.

Using different hair loss treatments at various times can improve results and reduce side effects for people with chronic hair loss.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Epidermal nevi are skin cell clusters linked to various syndromes.

Combining PRP with Minoxidil improves hair density and thickness more than Minoxidil alone.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

New regenerative therapies show promise for treating hair loss.

Paris polyphylla saponins may effectively treat acne due to their antibacterial and anti-inflammatory properties.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Rice husk and bran extracts from the Bue Bang 3 CMU variety can potentially treat hair loss due to their antioxidant, anti-inflammatory, and anti-androgenic properties.

Adult female acne is complex and requires a combination of treatments for effective management.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Origanum vulgare leaf extract reduces liver and kidney damage caused by finasteride in mice.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

New understanding and treatments for hair loss are improving, but more research is needed.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

PRP shows promise for treating hair loss but needs standardized methods to confirm its effectiveness.